Norwegian Cancer Precision Medicine Implementation Consortium
WHAT IS CONNECT?
CONNECT is a public-private consortium driving the implementation of precision cancer medicine by jointly addressing key obstacles and piloting novel solutions to transform the current practice.
The consortium has been initiated by 22 founding partners in December 2020, attracted 6 additional partners since then and is coordinated by Oslo Cancer Cluster. CONNECT gathers all Norwegian university hospitals, pharmaceutical and technology companies, the Norwegian Cancer Society as patient organisation, the Norwegian Institute of Public Health, the Norwegian Directorate of Health as well as the Norwegian Medicines Agency. The consortium is open to include new partners from the industry and public sector.
WHAT PEOPLE SAY
“A culture for public-private collaboration is not created through strategic plans, political ambitions or celebratory speeches, but through actions and behaviours that set a new standard.”
— Lars Petter Strand, Head of Medical at Novartis Oncology Norway
Partners
Upcoming Events
Thu, 27 JanOslo Cancer Cluster Innovation Park27 Jan, 11:30 – 16:00Oslo Cancer Cluster Innovation Park, Ullernchausseen 64-66, 0379 Oslo, NorgeCancer Crosslinks is an educational meeting series which promotes interactions between researchers and clinicians, and encourages translational and clinical research to support collaborations to advance the development of innovative cancer treatments. For details see www.cancercrosslinks.com
CONTACT US
Via Oslo Cancer Cluster
Ullernchausséen 64-66, 0379 Oslo
Jutta Heix, Project Manager, CONNECT
jh@oslocancercluster.no